| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |